Pfizer Share Price Target 2026 Analyst Forecast Bull and Bear Case

The Pfizer share price target, currently trading near its 52-week low of Rs 4,360, stands at Rs 6,215 for 2026, implying approximately 40% upside from the current market price of Rs 4,440. The stock trades at a price-to-earnings ratio of 27.87x, indicating balanced growth and value characteristics, with a market capitalisation of Rs 20,135 Cr. Investors tracking the pharmaceuticals segment are closely watching Pfizer as an emerging opportunity given its 52-week range of Rs 4,360 to Rs 5,896. This analysis covers the bull case, bear case, and key catalysts that will define the Pfizer share price target trajectory through 2026.

Click Here – Get Free Investment Predictions

Pfizer Company Overview and Key Metrics

Pfizer	Details
NSE Symbol	PFIZER
Sector	Pharmaceuticals
CMP (Rs)	4,440
52W High (Rs)	5,896
52W Low (Rs)	4,360
Market Cap (Rs Cr)	20,135 Cr
P/E Ratio	27.87
12M Target (Rs)	6,215
Bull Case (Rs)	7,145
Bear Case (Rs)	4,970

Pfizer is a pharmaceuticals company listed on the National Stock Exchange (NSE: PFIZER). With a market capitalisation of Rs 20,135 Cr, the company occupies a defined position in the Indian pharmaceuticals landscape. The stock has traded in a wide range over the past 12 months, touching a high of Rs 5,896 and a low of Rs 4,360, before arriving at its current level of Rs 4,440. Uniresearch analysts project a 12-month Pfizer share price target of Rs 6,215, with a bull case of Rs 7,145 and a bear case of Rs 4,970.

Why Is the Pfizer share price target Set at Rs 6,215 for 2026

FY27 Earnings Delivery and Revenue Acceleration

The Pfizer share price target of Rs 6,215 is anchored in expectations of FY27 earnings delivery. At a P/E of 27.87x on trailing earnings, the stock is priced for consistent execution. Consistent revenue growth and margin improvement in coming quarters can re-rate the stock towards the Rs 6,215 target.

Domestic Formulations Growth and NLEM Coverage

India’s pharma market is expanding at 10-12% annually driven by rising health awareness and increasing prescription volumes. Companies with a strong domestic branded generic presence are well-positioned to capture this structural demand growth.

USFDA and Export Approvals Pipeline

Pharma companies that successfully navigate USFDA inspections and build a credible ANDA pipeline can see significant margin expansion through regulated market sales. Export realizations are typically three to five times domestic pricing.

RBI Rate Cut Cycle and Lower Cost of Capital

The Reserve Bank of India has shifted to an accommodative monetary policy stance, with rate cuts reducing borrowing costs across the economy. For Pfizer, lower interest rates translate to reduced finance costs and potentially higher consumer demand in its end markets, creating a favourable backdrop for the Pfizer share price target to materialise by year-end.

Union Budget 2026 and Policy Tailwinds

The Union Budget 2026-27 has maintained strong capex allocation of Rs 11 lakh crore for infrastructure, directly benefiting sectors including pharmaceuticals. Tax rationalisation and sector-specific policy support create a constructive policy environment that supports the Pfizer share price target thesis through improved demand visibility.

Pfizer Share Price Target Short Term, 12 Month and Long Term

Short Term Pfizer Share Price Target: 3 to 6 Months

In the near term, the Pfizer share price target for the next 3 to 6 months is pegged at Rs 4,795, contingent on Q1 FY27 earnings meeting expectations and sustained buying interest in the pharmaceuticals segment. Technically, the stock needs to hold the Rs 4,578-4,796 zone for this short-term target to remain valid.

12 Month Pfizer Share Price Target 2026

Our 12-month Pfizer share price target is Rs 6,215. This target is based on the Uniresearch fundamental estimate, which factors in FY27 revenue growth, margin normalisation, and sector re-rating potential. The Rs 6,215 level represents approximately 40% upside from the current price of Rs 4,440.

Long Term Pfizer Share Price Target: FY27 to FY28

Over a 2 to 3 year horizon, the long-term Pfizer share price target is estimated between Rs 7,147 and Rs 8,390, assuming continued compounding in earnings, potential capacity expansions, and improved market positioning. Investors with a multi-year holding perspective may find the current CMP of Rs 4,440 an attractive accumulation level.

Bull Case and Bear Case for Pfizer Share Price Target

Bull Case: Rs 7,145

In the bull case scenario, Pfizer delivers above-estimate earnings growth driven by strong demand, margin expansion, and new business wins. If these catalysts materialise simultaneously, the Pfizer share price target could reach Rs 7,145, implying approximately 61% upside from the current market price.

Bear Case: Rs 4,970

The bear case of Rs 4,970 assumes earnings disappointment, sector-level de-rating, or broader market selloff driven by FII outflows. In this scenario, Pfizer could re-test support levels closer to its 52-week low of Rs 4,360, representing a downside risk investors should monitor.

Scenario	Target Price (Rs)	Upside/Downside from CMP	Key Assumption
Bull Case	7,145	61%	Strong earnings growth, sector re-rating
Base Case	6,215	40%	Steady earnings, margin improvement
Bear Case	4,970	12%	Earnings miss, macro headwinds

Key Risks to the Pfizer Share Price Target 2026

Macro Headwind from Global Slowdown and US Tariff Policy

A sharper-than-expected global slowdown or escalation in US-China trade tensions could dampen demand across sectors. Pfizer faces indirect risk if its customers or supply chain partners are impacted by slower global growth, as this could translate to lower order volumes or pricing pressure.

Valuation Risk and Earnings Miss Scenario

If Pfizer reports quarterly earnings below analyst estimates or provides weak forward guidance, the stock could see significant de-rating. Elevated valuations in some segments leave limited margin for error, making execution risk a critical near-term concern.

Competitive Pressure in the Pharmaceuticals Segment

The pharmaceuticals space in India is increasingly competitive with both domestic players and global companies vying for market share. Price competition, product commoditisation, or loss of key client contracts could pressure Pfizer’s revenue trajectory.

FII Selling and Broader Market Volatility

Foreign Institutional Investor selling in Indian equities has historically led to broad-based price corrections even in fundamentally sound companies. Pfizer’s share price could face near-term pressure if FII sentiment turns risk-off due to global monetary policy changes.

How to Invest in Pfizer Stock

Step 1: Research and Fundamental Analysis. Before investing, thoroughly review Pfizer’s quarterly results, annual report, and management commentary. Focus on revenue growth trajectory, operating margin trends, and debt levels to assess whether the Pfizer share price target of Rs 6,215 is achievable.

Step 2: Use Stock Screeners for Live Data.

Check Pfizer Live Data on Univest Screener

Monitor key metrics including P/E, return on equity, and promoter holding changes. These ratios can confirm or challenge the Pfizer share price target thesis in real time.

Step 3: Define Your Entry Zone. The current CMP of Rs 4,440 is within the identified accumulation zone based on the 52-week low of Rs 4,360 and the Uniresearch target of Rs 6,215. Consider entering in tranches to average your cost over market fluctuations.

Step 4: Set Stop Loss and Risk Management Levels. Always define a stop-loss level before investing. A prudent stop-loss for Pfizer based on the current technical setup would be in the Rs 3,907 to Rs 4,085 range. Never risk more than 2-5% of your portfolio in any single position.

Step 5: Open a Zero-Brokerage Demat Account. To invest in Pfizer at zero brokerage, open your demat account with Univest, which combines SEBI-registered research with integrated trading. This allows you to act on the Pfizer share price target analysis without incurring unnecessary transaction costs.

Download the Univest iOS App or Univest Android App to track Pfizer live price and get daily stock recommendations.

Conclusion

The Pfizer share price target for 2026 is Rs 6,215, with a bull case of Rs 7,145 and a bear case of Rs 4,970, based on Uniresearch estimates as of 29 June 2026. At a CMP of Rs 4,440 with a 52-week range of Rs 4,360 to Rs 5,896, Pfizer presents a risk-reward opportunity that warrants monitoring. Investors should review Q1 FY27 results, track management commentary on guidance, and consult a SEBI-registered advisor before making investment decisions. The Pfizer share price target outlined here is for educational purposes only.

FAQs on Pfizer Share Price Target 2026

What is the Pfizer share price target for 2026?

Ans. The Pfizer share price target for 2026, as per Uniresearch estimate, is Rs 6,215. This implies approximately 40% upside from the current market price of Rs 4,440.

Is Pfizer a good stock to buy right now?

Ans. Whether Pfizer is a good buy depends on your investment horizon, risk appetite, and portfolio allocation. The Uniresearch Pfizer share price target of Rs 6,215 implies meaningful upside, but investors must assess company fundamentals and market conditions before investing.

What is Pfizer’s 52-week high and low?

Ans. Pfizer’s 52-week high is Rs 5,896 and the 52-week low is Rs 4,360, as of 29 June 2026. The current price of Rs 4,440 represents a 2% gain from the 52-week low.

What is the market cap of Pfizer?

Ans. The market capitalisation of Pfizer is approximately Rs 20,135 Cr, as of 29 June 2026.

What are the key risks to the Pfizer share price target?

Ans. Key risks to the Pfizer share price target of Rs 6,215 include earnings disappointment, global macro headwinds, FII selling pressure, and competitive intensity in the pharmaceuticals sector. Any of these factors could delay or reduce the target realisation.

What is the bull case target for Pfizer in 2026?

Ans. In the bull case scenario, the Pfizer share price target could reach Rs 7,145, implying approximately 61% upside from the current level. This assumes stronger-than-expected earnings growth and sector re-rating.

Where can I track Pfizer share price live?

Ans. You can track Pfizer (NSE: PFIZER) live price, charts, and fundamental data on the Univest app or screener. The Univest platform provides real-time price data, analyst research, and portfolio tracking in one place.

How do I invest in Pfizer stock?

Ans. To invest in Pfizer, open a demat account with a SEBI-registered broker like Univest, which offers zero brokerage and integrated research. Search for the ticker PFIZER on NSE, review fundamentals using the Univest Screener, and invest based on your financial goals and risk profile.